HRS-1893 - Jiangsu Hengrui Pharma
A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Apr 22, 2025 - P2 | N=42 | Active, not recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Not yet recruiting ➔ Active, not recruiting | Trial primary completion date: Mar 2025 ➔ Nov 2024 
Enrollment closed • Trial primary completion date • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
http://clinicaltrials.gov/ct2/show/NCT06516068
 
Apr 22, 2025
 
Prev Next